PHS
CLPT icon

Pekin Hardy Strauss’s ClearPoint Neuro CLPT Stock Holding History

Pekin Hardy Strauss’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
+140,375
New +$1.77M 0.13% 181
2025
Q3 		– Sell
-50,575
Closed -$604K – 413
2025
Q2 		$604K Buy
50,575
+1,750
+4% +$22K 0.07% 223
2025
Q1 		$581K Buy
48,825
+575
+1% +$8.94K 0.07% 229
2024
Q4 		$742K Hold
48,250
– – 0.09% 197
2024
Q3 		$541K Buy
+48,250
New +$462K 0.07% 230

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Pekin Hardy Strauss's CLPT Position: Q1 2026 in Review

Pekin Hardy Strauss opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 140,375 shares worth $1.28M. The stake represents 0.13% of the portfolio and ranks #181 among its holdings. This is a return to the name: Pekin Hardy Strauss previously reported a position in CLPT as recently as Q2 2025.

Pekin Hardy Strauss first reported a position in CLPT in Q3 2024 and has held it in 5 quarters since. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Pekin Hardy Strauss held 140,375 shares of ClearPoint Neuro worth $1.28M as of Q1 2026.
  • ClearPoint Neuro was a new Pekin Hardy Strauss position in Q1 2026.
  • ClearPoint Neuro made up 0.13% of Pekin Hardy Strauss's portfolio in Q1 2026, its #181 holding.
  • Pekin Hardy Strauss first reported a position in ClearPoint Neuro in Q3 2024 and has held it in 5 quarters since.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.